European Commission Grants Ocugen Orphan Medicinal Product D

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis

globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Shankar Musunuri , Mohamed Genead , Nuclear Hormone Receptors , European Medicines Agency , European Commission , Ocugen Inc , Nasdaq , Leber Congenital , Chief Executive Officer , Retina Scientific Advisory Board , Acting Chief Medical Officer , Hormone Receptors , ஐரோப்பிய தரகு , நாஸ்டாக் , லேபேர் பிறவி , தலைமை நிர்வாகி அதிகாரி , நடிப்பு தலைமை மருத்துவ அதிகாரி ,